RosTrace

Tag: HealthcareInnovation

Robin Hayes

Expanded Access to Influenza Vaccination as NSW Pharmacists Begin Immunising Children Aged Two and Above

The New South Wales Government has announced a significant expansion of its influenza vaccination program, permitting qualified pharmacists to administer flu shots to children as young as two years old. The move, welcomed by the Pharmaceutical Society of Australia (PSA), aims to increase immunisation rates among young families, reduce barriers to access and ultimately curb the seasonal surge in influenza cases. With vaccination coverage among the six-month to five-year age group declining in recent years, health authorities are calling on all immunisation providers—GPs, nurse practitioners and pharmacists—to collaborate in safeguarding New South Wales communities this winter.

· 7 min read

Sage Bennett

Snakebite Survivor’s Blood Powers Breakthrough in Universal Antivenom Research

Tim Friede, a former truck mechanic from Wisconsin, has spent the past 18 years doing what most people would consider unthinkable: injecting himself with venom from some of the world’s deadliest snakes. His goal was never fame or notoriety — it was to build immunity and, ultimately, save lives. Now, thanks to his extraordinary biological resilience, Friede has helped scientists develop one of the most promising antivenoms to date — a universal treatment that could drastically change how snakebites are managed globally.

· 5 min read

Robin Hayes

New Biomarker Predicts Multiple Sclerosis Progression, Offering Hope for Better Treatment Strategies

Researchers at the University of Turku have identified a novel biomarker that may revolutionize how clinicians assess the progression and severity of multiple sclerosis (MS), a chronic autoimmune disease of the central nervous system. The groundbreaking study, published in Nature Medicine, offers promising new directions for both targeted treatment and faster development of therapeutic drugs—particularly for progressive MS, which remains one of the most challenging forms of the disease to treat.

· 3 min read

Ash Cooper

Tailored Biopsies Significantly Improve Patient Outcomes, ROME Trial Finds

CHICAGO – A groundbreaking clinical trial presented at the American Association for Cancer Research (AACR) Annual Meeting 2025 has demonstrated that patients with advanced solid tumors experience significantly improved survival outcomes when treatment is tailored using information from both tissue and liquid biopsies. The findings from the phase II, multicenter ROME trial could redefine the approach to precision oncology and patient care.

· 5 min read